Cartesian Therapeutics, Inc. (RNAC) bonds
RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.08−0.27 (-4.25%)
Close on Nov 16, 2026Market cap $183.95MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$52.85M
Long-term debt
Net debt
-$94.76M
After $147.61M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Cartesian Therapeutics's 10-Q for the period ended Jun 30, 2026
Cartesian Therapeutics's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| Loan Agreement | $150.00M | $53.48M |
See a number that looks wrong?